UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer
Phase 2
Completed
- Conditions
- Head and Neck CancerNeoplasms, OralNeoplasms, PharyngealCarcinoma, Squamous Cell
- Interventions
- Radiation: Intensity Modulated Radiation TherapyDrug: chemotherapy
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2022-03-17
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 72
- Registration Number
- NCT03067610
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT03067467
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET
Phase 2
Withdrawn
- Conditions
- Breast Cancer
- Interventions
- Drug: F-18 FluoroestradiolProcedure: Computed TomographyProcedure: Positron Emission TomographyOther: Laboratory Biomarker Analysis
- First Posted Date
- 2017-02-28
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT03065712
- Locations
- 🇺🇸
Clements University Hospital, Dallas, Texas, United States
SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients
Phase 2
Completed
- Conditions
- Kidney Cancer MetastaticKidney CancerKidney Cancer, Stage IV
- Interventions
- Drug: Nivolumab/IpilimumabRadiation: SBRT
- First Posted Date
- 2017-02-27
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT03065179
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸UT Southwestern, Dallas, Texas, United States
Promoting Activity in Cancer Survivors
Not Applicable
Completed
- Conditions
- Physical ActivityBreast Cancer
- Interventions
- Behavioral: Physical activity educationBehavioral: Facility accessBehavioral: Supervised exercise sessionsBehavioral: Self-monitoring (Fitbit)Behavioral: Active living counseling
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 355
- Registration Number
- NCT03060941
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
UTSW HP [13-C] Pyruvate Injection in HCM
Recruiting
- Conditions
- Duchenne Muscular DystrophyBecker Muscular DystrophyDilated CardiomyopathyHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection FractionCardiomyopathy, HypertrophicCardiac Sarcoidosis
- Interventions
- Diagnostic Test: Hyperpolarized 13C-Pyruvate
- First Posted Date
- 2017-02-17
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 128
- Registration Number
- NCT03057002
- Locations
- 🇺🇸
UT Southwestern Medical Center - Advanced Imaging Research Center, Dallas, Texas, United States
Breast Screening & Patient Navigation (BSPAN2): Evaluating a De-Centralized Regional Delivery System for Rural Underserved
Not Applicable
Completed
- Conditions
- Breast Cancer in Situ
- Interventions
- Behavioral: BSPAN
- First Posted Date
- 2017-02-14
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 18540
- Registration Number
- NCT03052907
Analysis of Neurocognitive Elements of Attention After Chemotherapy
Not Applicable
Completed
- Conditions
- Cancer Nos
- Interventions
- Other: Cognitive Assessment
- First Posted Date
- 2017-02-14
- Last Posted Date
- 2017-02-14
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT03052868
Impact of Liraglutide 3.0 on Body Fat Distribution
Phase 4
Completed
- Conditions
- Obesity, VisceralCardiovascular DiseasesFat Disorder
- Interventions
- Drug: PlaceboDrug: Liraglutide
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 235
- Registration Number
- NCT03038620
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Hypothermia and the Effect of Ambient Temperature 2
Not Applicable
Completed
- Conditions
- Neonatal OutcomeCesarean SectionHypothermia
- Interventions
- Other: Change in ambient operating room temperature
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 5221
- Registration Number
- NCT03008577
- Locations
- 🇺🇸
Parkland Memorial Hospital, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath